CRABP-II- and FABP5-independent all-trans retinoic acid resistance in COLO 16 human cutaneous squamous cancer cells

Experimental Dermatology

Volumn 21, Issue 1, 2012, Pages 13-18

  Chen, Nan Nan ^a,b   Li, Yan ^a   Wu, Mo Li ^a   Liu, Zhi Li ^a,c   Fu, Yuan Shan ^a   Kong, Qing You ^a   Chen, Xiao Yan ^a   Li, Hong ^a   Liu, Jia ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b The 210th Hospital of PLA   (China)

^c Dalian Hospital of Infectious Diseases   (China)

Author keywords

All trans retinoic acid; CRABP II; Cutaneous squamous cell carcinoma; DNA methylation; Drug resistance; FABP5; Gene transfection; SiRNA

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BISULFITE; CELLULAR RETINOIC ACID BINDING PROTEIN 2; CYTOCHROME P450 26A1; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 5; PLASMID VECTOR; RETINOIC ACID; RETINOIC ACID BINDING PROTEIN; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR GAMMA; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR BETA; RETINOID X RECEPTOR GAMMA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; DRUG SENSITIVITY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PLASMID; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; REGULATOR GENE; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC AGENTS; AZACITIDINE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CYTOCHROME P-450 ENZYME SYSTEM; DNA METHYLATION; DRUG RESISTANCE, NEOPLASM; FATTY ACID-BINDING PROTEINS; HUMANS; PPAR DELTA; RECEPTORS, RETINOIC ACID; SKIN NEOPLASMS; TRETINOIN;

EID: 83555162489     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2011.01392.x     Document Type: Article

References (34)

1. Jemal A, Siegel R, Ward E et al. CA Cancer J Clin 2008: 58: 71-96.
2. Yang L, Parkin D M, Ferlay J et al. Cancer Epidemiol Biomarkers Prev 2005: 14: 243-250.
3. Rowe D E, Carroll R J, Day C L Jr. J Am Acad Dermatol 1992: 26: 976-990.
4. Sakoe Y, Sakoe K, Kirito K et al. Blood 2010: 115: 3787-3795.
5. Quadro L, Hamberger L, Gottesman M E et al. Endocrinology 2005: 146: 4479-4490.
6. Lee G S, Kochhar D M, Collins M D. Curr Pharm Des 2004: 10: 2657-2699.
7. Freemantle S J, Spinella M J, Dmitrovsky E. Oncogene 2003: 22: 7305-7315.
8. Guidez F, Parks S, Wong H et al. Proc Natl Acad Sci USA 2007: 104: 18694-18699.
9. Gupta A, Kessler P, Rawwas J et al. Exp Cell Res 2008: 314: 3663-3668.
10. Schug T T, Berry D C, Shaw N S et al. Cell 2007: 129: 723-733.
11. Schug T T, Berry D C, Toshkov I A et al. Proc Natl Acad Sci USA 2008: 105: 7546-7551.
12. Kannan-Thulasiraman P, Seachrist D D, Mahabeleshwar G H et al. J Biol Chem 2010: 285: 19106-19115.
13. Moore G E, Merrick S B, Woods L K et al. Cancer Res 1975: 35: 2684-2688.
14. Denizot F, Lang R. J Immunol Methods 1986: 89: 271-277.
15. Li Y, Liu Z L, Zhang K L et al. Exp Dermatol 2009: 18: 842-848.
16. Lusher M E, Lindsey J C, Latif F et al. Cancer Res 2002: 62: 5906-5911.
17. Lind G E, Kleivi K, Meling G I et al. Cell Oncol 2006: 28: 259-272.
18. Wozniak R J, Klimecki W T, Lau S S et al. Oncogene 2007: 26: 77-90.
19. Li Y, Zhang K L, Sun Y et al. Transl Oncol 2008: 1: 165-176.
20. Bushue N, Wan Y J. Adv Drug Deliv Rev 2010: 62: 1285-1298.
21. Köbel M, Kalloger S E, Boyd N et al. PLoS Med 2008: 5: e232.
22. Meyskens F L Jr, Manetta A. Am J Clin Nutr 1995: 62: 1417-1419.
23. Zusi F C, Lorenzi M V, Vivat-Hannah V. Drug Discov Today 2002: 7: 1165-1174.
24. Lotan R. Cancer Res 1994: 54 (7 Suppl): 1987s-1990s.
25. Kunisada M, Budiyanto A, Bito T et al. Br J Dermatol 2005: 152: 435-443.
26. Shin D M, Glisson B S, Khuri F R et al. J Clin Oncol 2002: 20: 364-370.
27. McCaffery P, Dräger U C. Cytokine Growth Factor Rev 2000: 11: 233-249.
28. Karlsson T, Vahlquist A, Törmä H. J Dermatol Sci 2010: 57: 207-213.
29. Calmon M F, Rodrigues R V, Kaneto C M et al. Neoplasia 2009: 11: 1329-1339.
30. Gillespie R F, Gudas L J. J Biol Chem 2007: 282: 33421-33434.
31. Shelton D N, Sandoval I T, Eisinger A et al. Cancer Res 2006: 66: 7571-7577.
32. Wahl M B, Deng C, Lewandoski M et al. Development 2007: 134: 4033-4041.
33. Li Y, Sawalha A H, Lu Q. J Dermatol Sci 2009: 54: 143-149.
34. Aggarwal S, Kim S W, Cheon K et al. Mol Cell Biol 2006: 17: 2566-2575.